Characteristics of [3H]fentanyl binding to the opiate receptor

The present study characterises the binding of the highly lipophilic opiate agonist [3H]fentanyl to homogenates of the rat central nervous system. At 25 degrees C, association of [3H]fentanyl with its binding site was rapid (t1/2 = 2.5 min). Dissociation from the binding site was biphasic (t1/2's = 4.0 and 100 min) suggesting the existence of high and low affinity binding sites. Scatchard plots of saturation isotherms were curvilinear, confirming the presence of high (KD = 0.46 nM) and low KD = 4.26 nM) affinity binding sites. Increasing temperature and the concentration of sodium ion decreased the [3H]fentanyl binding. Opiate agonists, antagonists and mixed agonist-antagonists were all potent (IC50's less than 20 nM) in displacing [3H]fentanyl and displacement by levorphanol and dextrorphan indicated that [3H]fentanyl binding was stereospecific. The mu and delta selective peptides, morphiceptin and [D-Ala2,D-Leu5]enkephalin, had IC50 values of 87 and 9.2 nM respectively. The regional distribution of [3H]fentanyl binding was in the rank order striatum approximately equal to midbrain greater than hypothalamus greater than cortex greater than hippocampus greater than brainstem greater than spinal cord greater than cerebellum. Comparison of [3H]fentanyl, [3H]naloxone and [3H-D-Ala2,D-Leu5]enkephalin binding in the hypothalamus-thalamus (mu-enriched) compared with the frontal cortex-striatum (delta-enriched) indicated that the pattern of [3H]fentanyl labelling was similar to that obtained with [3H]naloxone, but differed from that obtained with [3H-D-Ala2,D-Leu5]enkephalin. These characteristics suggest that [3H]fentanyl binds to the mu-opiate receptor. These findings are discussed in relation to the high lipid solubility of fentanyl as compared with morphine.

[1]  L. Iversen,et al.  Multiple opiate receptor sites on primary afferent fibres , 1980, Nature.

[2]  K. Taylor,et al.  Buprenorphine : characteristics of binding sites in the rat central nervous system. , 1981, Life sciences.

[3]  P. Cuatrecasas,et al.  Multiple opiate receptors: different regional distribution in the brain and differential binding of opiates and opioid peptides. , 1979, Molecular pharmacology.

[4]  H. Loh,et al.  3H-Leu5-enkephalin specific binding to synaptic membrane-comparison with 3H-dihydromorphine and 3H-naloxone. , 1978, Research communications in chemical pathology and pharmacology.

[5]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[6]  M. Kuhar,et al.  Neurotransmitter Receptor Binding , 1984 .

[7]  J. Leysen,et al.  Differential distribution of opiate and neuroleptic receptors and dopamine-sensitive adenylate cyclase in rat brain. , 1977, Life sciences.

[8]  R. Rothman,et al.  Allosteric coupling between morphine and enkephalin receptors in vitro. , 1982, Molecular pharmacology.

[9]  I. Creese,et al.  Opiate receptor binding affected differentially by opiates and opioid peptides. , 1979, European journal of pharmacology.

[10]  S. Snyder,et al.  Discrimination by temperature of opiate agonist and antagonist receptor binding. , 1975, Life sciences.

[11]  L. Terenius Contribution of ‘receptor’ affinity to analgesic potency , 1974, The Journal of pharmacy and pharmacology.

[12]  P. Cuatrecasas,et al.  Morphiceptin (NH4-tyr-pro-phe-pro-COHN2): a potent and specific agonist for morphine (mu) receptors. , 1981, Science.

[13]  S. Snyder,et al.  Differential effects of protein-modifying reagents on receptor binding of opiate agonists and antagonists. , 1975, Molecular pharmacology.

[14]  D. Hunston Two techniques for evaluating small molecule-macromolecule binding in complex system , 1975 .